COVID-19 began in Wuhan (China) in December 2019 and has since expanded rapidly throughout the world. In terms of confirmed cases and reported deaths, the United States, India, Brazil, Russia, France, the United Kingdom, Turkey, Italy, and Spain are among the worst impacted countries. Due to lockdowns, travel bans, and commercial shutdowns, the COVID-19 has had an impact on economies and businesses in a number of countries. The closure of numerous plants and factories has impacted worldwide supply chains, negatively impacting manufacturing, delivery schedules, and product sales in the global market. However, in the case of the biomarkers market, they play a critical role in the development of treatments for chronic diseases, where the government and pharmaceutical businesses invest heavily.
Read More:
https://knackersblogger.blogspot.com/2022/07/the-increasing-use-of-diagnostic.html
